1. Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States 
Austin G. Stack, Bhamidipati V.R. Murthy, Donald A. Molony 
Kidney International 
Volume 65, Issue 6, Pages (June 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (<20.9 kg/m2). All models adjusted for age at study start, gender, race, hypertension, coronary artery disease, cardiac arrest/arrhythmia, peripheral vascular and cerebrovascular disease, congestive heart failure, tobacco use, chronic lung disease, AIDS, neoplasm, alcohol dependence, serum albumin, hematocrit, estimated glomerular filtration rate, functional status (inability to walk and transfer), and pre-ESRD erythropoietin use.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (20.9–23.5 kg/m2).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

4. Figure 3
Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (23.5–26.1 kg/m2).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

5. Figure 4
Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (26.1–30.0 kg/m2).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

6. Figure 5
Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (>30.0 kg/m2).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

7. Figure 6
Relative risk of death by body mass index (BMI) quintile for new end-stage renal disease (ESRD) patients treated with hemodialysis. All models adjusted for age at study start, gender, race, hypertension, coronary artery disease, cardiac arrest/arrhythmia, peripheral vascular and cerebrovascular disease, congestive heart failure, tobacco use, chronic lung disease, AIDS, neoplasm, alcohol dependence, serum albumin, hematocrit, estimated glomerular filtration rate, functional status (inability to walk and transfer), and pre-ESRD erythropoietin use. *P < 0.05; **P < 0.01; ***P < compared to a relative risk of Reference BMI 23.5–26.1 kg/m2.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

8. Figure 7
Relative risk of death by body mass index (BMI) quintile for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis. All models adjusted for age at study start, gender, race, hypertension, coronary artery disease, cardiac arrest/arrhythmia, peripheral vascular and cerebrovascular disease, congestive heart failure, tobacco use, chronic lung disease, AIDS, neoplasm, alcohol dependence, serum albumin, hematocrit, estimated glomerular filtration rate, functional status (inability to walk and transfer), and pre-ESRD erythropoietin use. *P < 0.05; **P < 0.01; ***P < compared to a relative risk of Reference BMI 23.5–26.1 kg/m2.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions